XML 112 R120.htm IDEA: XBRL DOCUMENT v2.4.0.8
Schedule II - Condensed Financial Information of Registrant (Statements of Cash Flows (Parent Company)) (Details) (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Condensed Cash Flow Statements, Captions [Line Items]      
Fixed maturity securities available for sale at fair value (cost $61,084 and $281,708 at December 31, 2013 and 2012, respectively) $ 11,616,844 $ 11,943,956  
Cash flows from operating activities:      
Net income 499,925 510,592 391,211
Adjustments to reconcile net income to net cash from operating activities:      
Net investment gains (121,544) (210,465) (125,481)
Depreciation and amortization 103,090 103,419 88,012
Stock incentive plans 23,784 26,763 27,175
Change in:      
Other liabilities (2,826) 107,928 10,269
Net cash from operating activities 819,798 675,458 670,279
Cash from (used in) investing activities:      
Proceeds from sale of fixed maturity securities 1,344,707 838,576 1,293,876
Proceeds from maturities and prepayments of fixed maturity securities 2,718,156 2,291,105 1,697,144
Proceeds from sales of equity securities 267,554 409,610 159,827
Cost of purchases of fixed maturity securities (4,198,135) (3,617,002) (2,815,340)
Payments to Acquire Available-for-sale Securities, Equity (156,557) (284,991) (97,986)
Change in balance due to security broker (26,155) (25,799) (16,194)
Net additions to real estate, furniture & equipment (63,150) (40,556) (45,320)
Net cash used investing activities (545,364) (775,068) (204,274)
Cash from (used in) financing activities:      
Net proceeds from stock options exercised 53 7,660 21,963
Purchase of common treasury shares (166,473) (127,663) (187,163)
Cash dividends to common stockholders (52,717) (183,947) (43,253)
Net cash from (used in) financing activities (330,262) 97,192 (195,213)
Net increase (decrease) in cash and cash equivalents (65,932) (6,072) 268,790
Cash and cash equivalents at beginning of year 905,670 911,742 642,952
Cash and cash equivalents at end of year 839,738 905,670 911,742
Parent Company
     
Condensed Cash Flow Statements, Captions [Line Items]      
Fixed maturity securities available for sale at fair value (cost $61,084 and $281,708 at December 31, 2013 and 2012, respectively) 63,115 286,597  
Cash flows from operating activities:      
Net income 499,925 510,592 391,211
Adjustments to reconcile net income to net cash from operating activities:      
Net investment gains (24,550) (71,130) (45,962)
Depreciation and amortization 10,397 5,624 4,905
Equity in undistributed earnings of subsidiaries (369,640) (694,701) (71,146)
Tax payments received from subsidiaries 77,305 125,046 139,011
Federal income taxes provided by subsidiaries on a separate return basis (225,845) (132,379) (79,200)
Stock incentive plans 24,594 26,763 27,176
Change in:      
Federal income taxes 21,866 44,423 56,542
Other assets (821) 911 (542)
Other liabilities (16,280) 28,017 (6,747)
Accrued investment income 967 97 1,559
Other, net 0 (13) 277
Net cash from operating activities (2,082) (156,750) 417,084
Cash from (used in) investing activities:      
Proceeds from sale of fixed maturity securities 230,854 93,354 70,665
Proceeds from maturities and prepayments of fixed maturity securities 68,918 121,191 165,158
Proceeds from sales of equity securities 23,395 72,565 47,735
Cost of purchases of fixed maturity securities (79,132) (255,885) (240,536)
Payments to Acquire Available-for-sale Securities, Equity (4,668) 0 0
Investments in and advances to subsidiaries, net (58,454) (16,480) (3,867)
Change in balance due to security broker 6,918 (4,767) (5,983)
Net additions to real estate, furniture & equipment (1,896) (1,857) (643)
Net cash used investing activities 185,935 8,121 32,529
Cash from (used in) financing activities:      
Net proceeds from issuance of senior notes 339,627 345,823 0
Net proceeds from stock options exercised 53 13,544 21,966
Repayment of senior notes (450,000) 0 0
Purchase of common treasury shares (166,473) (134,456) (187,163)
Cash dividends to common stockholders (52,717) (183,947) (43,255)
Net cash from (used in) financing activities (329,510) 40,964 (208,452)
Net increase (decrease) in cash and cash equivalents (145,657) (107,665) 241,161
Cash and cash equivalents at beginning of year 162,972 270,637 29,476
Cash and cash equivalents at end of year $ 17,315 $ 162,972 $ 270,637